PSMAfore: A phase III study to compare (177)Lu-PSMA-617 treatment with a change in androgen receptor pathway inhibitor in taxane-naive patients with mCRPC Meeting Abstract
| Authors: | Morris, M. J.; Sartor, O.; Chi, K. N.; de Bono, J. S.; Shore, N. D.; Crosby, M.; Dalal, D.; Fizazi, K. |
| Abstract Title: | PSMAfore: A phase III study to compare (177)Lu-PSMA-617 treatment with a change in androgen receptor pathway inhibitor in taxane-naive patients with mCRPC |
| Meeting Title: | ESMO Congress 2021 |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2021 Sep 16-21 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-09-01 |
| Start Page: | S675 |
| End Page: | S676 |
| Language: | English |
| ACCESSION: | WOS:000700527701114 |
| DOI: | 10.1016/j.annonc.2021.08.1161 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 648TiP -- Source: Wos |
